As the need for medical care in patients with HF and diabetes increases and the standard treatments are lacking [6], DPP-4 inhibitors and GLP-1 RAs, both anti-diabetic drugs, have shown beneficial effects in improving exercise tolerance in HF patients. The gene discussed is GLP1R; the disease is hydrops fetalis.